Dr. Reddy's upgraded by HSBC Securities with a new price target
$RDY
Biotechnology: Pharmaceutical Preparations
Health Care
HSBC Securities upgraded Dr. Reddy's from Hold to Buy and set a new price target of $16.90
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
6/5/2025 | $16.89 | Hold → Buy | HSBC Securities |
12/19/2024 | Buy → Neutral | Nomura | |
1/11/2024 | Buy → Underperform | Jefferies | |
8/29/2023 | Buy → Hold | HSBC Securities | |
5/18/2023 | Outperform → Mkt Perform | Bernstein | |
3/17/2023 | Neutral → Buy | BofA Securities | |
1/30/2023 | Underweight | JP Morgan | |
11/14/2022 | Neutral → Underperform | Credit Suisse |